DNAJC5 and acute kidney injury: Since clinical exploitation with Csp carries a risk of acute kidney injury, these findings suggest that combination of PBE may be a potential therapeutic adjuvant against Csp-induced nephrotoxicity and various kidney injuries caused by oxidative stress.